CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment
CanBas: Company presentation materials 2024/5 3rd quarter financial results reflection version
CanBas: Notice regarding the recording of non-operating profit and loss
CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment
CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment
Canvas: Company Presentation Materials March 2024 Edition
Canvas: Notice regarding the monthly exercise status of stock acquisition rights with price correction clauses exercised through third-party allotment
Canvas: Notice of publication in a journal on CBP501 clinical phase 2 trial results (progress of disclosure information)
Canvas: Explanatory materials on business plans and growth potential (2024/2 updated version)
Canvas: Announcement of the start of discussions with the EMA for the start of the CBP501 European Clinical Phase 3 trial
Canvas: Notice of publication in a journal on CBP501 clinical phase 2 trial results
CanBas: Supplementary Q&A announcement on “CBP501 Next Phase Clinical Trial Schedule in the US and Clinical Phase 3 Clinical Trial Preparation in Europe” published on 2/9
CanBas: Next phase clinical trial schedule for CBP501 in the US and preparations for clinical phase 3 clinical trials in Europe
CanBas: Notice regarding the recording of non-operating expenses
CanBas: Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Amendment Clauses through Third-Party Allotment
CanBas: Notice of expansion and extension of research collaboration with Nihon University School of Medicine regarding the anticancer drug candidate compound CBT005
CanBas: Company presentation materials 2024/1
CanBas: Notice regarding the monthly exercise status of stock acquisition rights with price correction clauses exercised through third-party allotment
CanBas: Company presentation materials December 2023 edition
CanBas: Notice Concerning Mass Exercise of Stock Acquisition Rights with Exercise Price Amendment Clause
No Data